SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2188703

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2188703

U.S. Cataract Surgery Site-of-Care Market Size, Share & Trends Analysis Report By Product (IOLs, Surgical Systems & Visualization, Instruments & Disposables, OVDs, Others), By CPT Codes, By Payer, By End Use, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 3950
Printable PDF & Excel (5-User License)
USD 4950
Printable PDF & Excel (Enterprise License)
USD 6950

Add to Cart

U.S. Cataract Surgery Site-of-Care Market Summary

The U.S. cataract surgery site-of-care market size was valued at USD 18.0 billion in 2025 and is projected to grow from USD 18.7 billion in 2026 to USD 24.2 billion by 2033, at a CAGR of 3.7% from 2026 to 2033. The U.S. cataract surgery site-of-care market is supported by the high prevalence of cataracts, an aging population, and the growing need for surgical treatment to maintain vision and quality of life. Cataracts develop when the natural lens of the eye becomes cloudy, leading to blurred vision, glare, and difficulty performing daily activities.

According to the American Academy of Ophthalmology (AAO), almost 4 million Americans have gone through cataract surgery every year. Moreover, the AAO estimates that the number of people in the U.S. who will develop cataracts will rise from 24.4 million to 50 million by 2050, which means there will be significantly more cataract procedures. Therefore, hospitals, ambulatory surgery centers (ASCs), and eye surgery facilities can benefit from the growing demand for cataract surgeries.

The most frequent type of cataract surgery is inpatient, but some procedures can also be outpatient, making such facilities critical to meet the expanding need for the service. Surgeries can often be completed on an outpatient basis, making them more accessible to patients and less costly to insurers. ASCs can help eye surgeons complete such procedures while providing a controlled environment for post-surgery recovery. Moreover, ASCs may report paying roughly 62% of the HOPD rates for the same procedures, according to an analysis of Medicare data conducted by ASCA and released in May 2026. The report also stated that eye surgery is among the most common types of surgery performed in ASCs. Thus, a less expensive alternative to traditional hospitals is a compelling choice for payers, physicians, and patients, but specific cases will dictate whether a procedure will be performed in an inpatient or outpatient setting.

Medicare reimbursement policies and regulations are also significant external factors that may affect the market. Specifically, CMS's payment rules and policies for services rendered in ASCs and HOPDs create a financial basis for determining the viability of providing services in these settings. On November 21, 2025, CMS published its 2026 outpatient payment rule, which includes a 2.6 percent payment update for certified ASCs and HOPDs. According to ASCA, the final rule will increase Medicare reimbursement for CPT 66984 code ("Cataract removal with intraocular lens implantation, with intraoperative microscope"), a common procedure for treating cataracts, by 3.4 percent compared to 2025. The stability of reimbursements and their payment updates are two crucial factors for healthcare facilities, dictating their development plans and influencing the choice between HOPD and ASC. Nevertheless, reimbursement growth is not the sole determinant of the market's development and healthcare providers' choices, as an organization should consider multiple costs associated with care delivery, including personnel, equipment, and quality of care, among others, and analyze the competitive landscape.

Technological advances to eye surgery equipment are further shaping provider investment and service trends. Modern phacoemulsification devices, sophisticated intraocular lenses, enhanced surgical instruments, and digital planning solutions contribute to ophthalmologists' ability to design procedures and address a variety of patient needs. In April 2025, the ZEISS Medical Technology announced that more than 2 million cataract procedures in the United States have been digitally planned using its VERACITY Surgery Planner, illustrating the adoption of digital solutions by the eye surgery sector. Similarly, in June 2025, Alcon launched its Unity cataract surgery platform at a U.S. clinic, representing another step in the industry's commitment to investing into leading-edge surgical equipment. The developments in question are expected to increase productivity and differentiate providers within the setting of an ambulatory surgery center (ASC) or a hospital's outpatient department. That said, the cost of embracing the progress may challenge some smaller facilities, while the selection of a specific technology will depend on the needs of a given site and the scope of its projected surgical volume.

U.S. Cataract Surgery Site-of-Care Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. cataract surgery site-of-care market report based on product, CPT code, payer, end use:

  • Product Outlook (Revenue, USD Unit, 2021 - 2033)
  • IOLs
  • Surgical Systems & Visualization
  • Instruments & Disposables
  • OVDs
  • Others
  • CPT Code Outlook (Revenue, USD Unit, 2021 - 2033)
  • 66982 (complex cataract surgeries)
  • 66984 (routine cataract surgeries)
  • 66991, 66989 (cataracts with MIGS)
  • Others
  • Payer Outlook (Revenue, USD Unit, 2021 - 2033)
  • Medicare
  • Medicaid
  • Commercial Insurance
  • Others (self pay, VA and etc)
  • End Use Outlook (Revenue, USD Unit, 2021 - 2033)
  • Hospital Outpatient Departments (HOPDs)
  • Ambulatory Surgery Centers (ASCs)
  • Office-Based Surgery (OBS) & independent clinics
Product Code: GVR-4-68041-066-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. CPT Code
    • 1.2.3. Payer
    • 1.2.4. End Use
    • 1.2.5. Country scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. CPT Code outlook
    • 2.2.3. Payer outlook
    • 2.2.4. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Cataract Surgery Site-of-Care Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Cataract Surgery Site-of-Care Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Cataract Surgery Site-of-Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Cataract Surgery Site-of-Care Market: Product Movement Analysis
  • 4.3. U.S. Cataract Surgery Site-of-Care Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. IOLs
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Surgical Systems & Visualization
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Instruments & Disposables
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. OVDs
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Cataract Surgery Site-of-Care Market: CPT Code Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Cataract Surgery Site-of-Care Market: CPT Code Movement Analysis
  • 5.3. U.S. Cataract Surgery Site-of-Care Market by CPT Code Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. 66982 (complex cataract surgeries)
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. 66984 (routine cataract surgeries)
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. 66991, 66989 (cataracts with MIGS)
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Cataract Surgery Site-of-Care Market: Payer Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Cataract Surgery Site-of-Care Market: Payer Movement Analysis
  • 6.3. U.S. Cataract Surgery Site-of-Care Market by Payer Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Medicare
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Medicaid
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Commercial Insurance
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Cataract Surgery Site-of-Care Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Cataract Surgery Site-of-Care Market: End Use Movement Analysis
  • 7.3. U.S. Cataract Surgery Site-of-Care Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Hospital Outpatient Departments (HOPDs)
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Ambulatory Surgery Centers (ASCs)
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Office-Based Surgery (OBS) & independent clinics
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. SCA Health
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product/Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. USPI (Tenet)
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product/Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. EyeSouth Partners
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product/Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Unifeye Vision Partners
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product/Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Bascom Palmer Eye Institute (Univ. of Miami)
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product/Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Wills Eye Hospital
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product/Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Cole Eye Institute (Cleveland Clinic)
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product/Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Massachusetts Eye and Ear
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product/Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. EyeCare Partners
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product/Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Eye Health America
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product/Service Benchmarking
      • 8.2.10.4. Strategic Initiatives
Product Code: GVR-4-68041-066-4

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. cataract surgery site-of-care market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. cataract surgery site-of-care market, by CPT code, 2021 - 2033 (USD Million)
  • Table 5 U.S. cataract surgery site-of-care market, by payer, 2021 - 2033 (USD Million)
  • Table 6 U.S. cataract surgery site-of-care market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig 1. U.S. cataract surgery site-of-care market segmentation
  • Fig 2. Market research process
  • Fig 3. Data triangulation techniques
  • Fig 4. Primary research pattern
  • Fig 5. Market research approaches
  • Fig 6. Value-chain-based sizing & forecasting
  • Fig 7. Market formulation & validation
  • Fig 8. Market snapshot
  • Fig 9. Product & CPT code outlook (USD Million)
  • Fig 10. Payer & end use outlook (USD Million)
  • Fig 11. Competitive landscape
  • Fig 12. U.S. cataract surgery site-of-care market dynamics
  • Fig 13. U.S. cataract surgery site-of-care market: Porter's five forces analysis
  • Fig 14. U.S. cataract surgery site-of-care market: PESTLE analysis
  • Fig 15. U.S. cataract surgery site-of-care market: Product segment dashboard
  • Fig 16. U.S. cataract surgery site-of-care market: Product market share analysis, 2025 & 2033
  • Fig 17. IOLs market, 2021 - 2033 (USD Million)
  • Fig 18. Surgical Systems & Visualization market, 2021 - 2033 (USD Million)
  • Fig 19. Instruments & Disposables market, 2021 - 2033 (USD Million)
  • Fig 20. OVDs market, 2021 - 2033 (USD Million)
  • Fig 21. Others market, 2021 - 2033 (USD Million)
  • Fig 22. U.S. cataract surgery site-of-care market: CPT code segment dashboard
  • Fig 23. U.S. cataract surgery site-of-care market: CPT code market share analysis, 2025 & 2033
  • Fig 24. 66982 (complex cataract surgeries) market, 2021 - 2033 (USD Million)
  • Fig 25. 66984 (routine cataract surgeries) market, 2021 - 2033 (USD Million)
  • Fig 26. 66991, 66989 (cataracts with MIGS) market, 2021 - 2033 (USD Million)
  • Fig 27. Others market, 2021 - 2033 (USD Million)
  • Fig 28. U.S. cataract surgery site-of-care market: Payer segment dashboard
  • Fig 29. U.S. cataract surgery site-of-care market: Payer market share analysis, 2025 & 2033
  • Fig 30. Medicare market, 2021 - 2033 (USD Million)
  • Fig 31. Medicaid market, 2021 - 2033 (USD Million)
  • Fig 32. Commercial Insurance market, 2021 - 2033 (USD Million)
  • Fig 33. Others market, 2021 - 2033 (USD Million)
  • Fig 34. U.S. cataract surgery site-of-care market: End use segment dashboard
  • Fig 35. U.S. cataract surgery site-of-care market: End use market share analysis, 2025 & 2033
  • Fig 36. Hospital Outpatient Departments (HOPDs) market, 2021 - 2033 (USD Million)
  • Fig 37. Ambulatory Surgery Centers (ASCs) market, 2021 - 2033 (USD Million)
  • Fig 38. Office-Based Surgery (OBS) & independent clinics market, 2021 - 2033 (USD Million)
  • Fig 39. Company categorization
  • Fig 40. Company market position analysis
  • Fig 41. Strategic framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!